Literature DB >> 10798533

NMR investigation of the complexation of daunomycin with deoxytetranucleotides of different base sequence in aqueous solution.

D B Davies1, R J Eaton, S F Baranovsky, A N Veselkov.   

Abstract

500 MHz NMR spectroscopy has been used to investigate the complexation of the anthracycline antibiotic daunomycin (DAU) with self-complementary deoxytetranucleotides, 5'-d(CGCG), 5'-d(GCGC), 5'-d(TGCA), 5'-d(ACGT) and 5'-d(AGCT), of different base sequence in aqueous salt solution. 2D homonuclear 1H NMR spectroscopy (TOCSY and NOESY) and heteronuclear 1H - 31P NMR spectroscopy (HMBC) have been used for complete assignment of the non-exchangeable protons and the phosphorus resonance signals, respectively, and for a qualitative determination of the preferred binding sites of the drug. Analysis shows that DAU intercalates preferentially into the terminal sites of each of the tetranucleotides and that the aminosugar of the antibiotic is situated in the minor groove of the tetramer duplex, partly eclipsing the third base pair. A quantitative determination of the complexation of DAU with the deoxytetranucleotides has been made using the experimental concentration and temperature dependences of the drug proton chemical shifts; these have been analysed in terms of the equilibrium reaction constants, limiting proton chemical shifts and thermodynamical parameters (enthalpies deltaH, entropies deltaS) of different drug-DNA complexes (1:1, 1:2, 2:1, 2:2) in aqueous solution. It is found that DAU interacts with sites containing three adjacent base pairs but does not show any significant sequence specificity of binding with either single or double-stranded tetranucleotides, in contrast with other intercalating drugs such as proflavine, ethidium bromide and actinomycin D. The most favourable structures of the 1:2 complexes have been derived from the induced limiting proton chemical shifts of the drug in the intercalated complexes with the tetranucleotide duplex, in conjunction with 2D NOE data. It has been found that the conformational parameters of the double helix and the orientation of the DAU chromophore in the intercalated complexes depend on base sequence at the binding site of the tetramer duplexes in aqueous solution.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798533     DOI: 10.1080/07391102.2000.10506577

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

1.  Complexation of anthracycline drugs with DNA in the presence of caffeine.

Authors:  M P Evstigneev; V V Khomich; D B Davies
Journal:  Eur Biophys J       Date:  2006-10-24       Impact factor: 1.733

2.  The use of 1H-31P GHMBC and covariance NMR to unambiguously determine phosphate ester linkages in complex polysaccharide mixtures.

Authors:  Edward R Zartler; Gary E Martin
Journal:  J Biomol NMR       Date:  2011-09-16       Impact factor: 2.835

3.  Complexation of biologically active aromatic compounds with DNA in the presence of theophylline.

Authors:  A A Hernandez Santiago; D D Andrejuk; A M Cervantes Tavera; D B Davies; M P Evstigneev
Journal:  J Biol Phys       Date:  2009-01-10       Impact factor: 1.365

4.  Auto-FACE: an NMR based binding site mapping program for fast chemical exchange protein-ligand systems.

Authors:  Janarthanan Krishnamoorthy; Victor C K Yu; Yu-Keung Mok
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 5.  Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.

Authors:  Jia Sheng; Jianhua Gan; Zhen Huang
Journal:  Med Res Rev       Date:  2013-04-30       Impact factor: 12.944

Review 6.  Recent Advances in Developing Small Molecules Targeting Nucleic Acid.

Authors:  Maolin Wang; Yuanyuan Yu; Chao Liang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-05-30       Impact factor: 5.923

Review 7.  An overview of recent advances in duplex DNA recognition by small molecules.

Authors:  Sayantan Bhaduri; Nihar Ranjan; Dev P Arya
Journal:  Beilstein J Org Chem       Date:  2018-05-16       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.